Document Detail

Trials in kidney disease--time to EVOLVE.
MedLine Citation:
PMID:  23121375     Owner:  NLM     Status:  MEDLINE    
Vlado Perkovic; Bruce Neal
Related Documents :
24448075 - Impact of diabetes mellitus and renal insufficiency on 5-year mortality following coron...
25388955 - Phenotypic identification of subclones in multiple myeloma with different chemoresistan...
25114135 - A clinical adverse drug reaction prediction model for patients with chagas disease trea...
23075605 - The impact of estimated glomerular filtration rate reporting on nephrology referral pat...
9510315 - Perianal infections in patients with leukemia: importance of the course of neutrophil c...
23172655 - Capacity of forensic patients to consent to treatment.
Publication Detail:
Type:  Comment; Editorial     Date:  2012-11-03
Journal Detail:
Title:  The New England journal of medicine     Volume:  367     ISSN:  1533-4406     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-27     Completed Date:  2013-01-07     Revised Date:  2013-05-30    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2541-2     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Diseases / prevention & control*
Hyperparathyroidism, Secondary / drug therapy*
Kidney Failure, Chronic / drug therapy*
Naphthalenes / therapeutic use*
Renal Dialysis*
Reg. No./Substance:
0/Naphthalenes; UAZ6V7728S/cinacalcet
Comment On:
N Engl J Med. 2012 Dec 27;367(26):2482-94   [PMID:  23121374 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
Next Document:  Aquaretic Treatment in Polycystic Kidney Disease.